We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Policy

Cannabis Policy

CBD Oil Product Recalled Due to High Lead Levels, FDA Announces

According to a Florida state department, a sample of a Kore Organic Watermelon CBD oil tincture, produced by Summitt Labs, contained 4.7 parts per million of lead.

Read More

Californian Cannabis Businesses Now Have 60 More Days to Renew their Licenses

As Covid-19 continues to disrupt cannabis businesses across the US, some of those in California may have struggled to renew their licenses before the June 30 deadline.

Read More

Researchers Pinpoint the Ideal Legal Age for Cannabis Use

It's 19 in most Canadian provinces, but 21 in all US states with legal access. So which is the ideal age threshold to buy recreational marijuana? One group of researchers think they have the answer.

Read More

The ACI Sets its First Standards for CBD Testing in the UK

CBD is more popular than ever in the UK, but its testing standards are hardly high, say the ACI.

Read More

How to Grow a New Cannabis Business Amid a Pandemic

The pandemic has changed our lives beyond recognition, but it doesn’t have to spell the end of your cannabis business, writes Hannah Deacon.

Read More

Massachusetts Recreational Cannabis Stores Anticipate Reopening

Recreational cannabis stores have been closed in Massachusetts since March 24 after being ruled to be “non-essential” businesses.

Read More

Illicit Cannabis Sales Soar in Europe Amid Lockdowns, Report Finds

The new report, which analysed transactions on the darknet, found that illicit cannabis sales increased by about 30 percent during the first quarter of 2020.

Read More

Legal Cannabis Sales Nearly Doubled From 2018 to 2019, Report Finds

From 2018 to 2019, global legal cannabis sales grew by 46 percent up to US$14.8 billion, according to new analysis.

Read More

First Prescriptions Arrive for Europe’s Largest Medical Cannabis Trial

Supplied by the Latin American company Khiron Life Sciences, the cannabis products will first be issued to UK doctors before being prescribed to the 20,000 patients expected to be involved in the trial.

Read More

 
Advertisement